Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLGN
#3898
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-1.72%
Aylık değişim
-70.62%
6 aylık değişim
-79.86%
Yıllık değişim
-83.71%
Önceki kapanış
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Hacim
1
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
CLGN
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
11.45 M
44.87 M
Valuation ratios
Enterprise value
29.33 M
345.14 M
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
3.06
12.77
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
4.29
37.03
Current ratio
4.44
38.21
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
1.04
7.17
Net current asset value per share
1.15
10.25
Tangible book value per share
1.16
10.29
Working capital per share
0.89
9.17
Book value per share
1.18
10.36
Haberler
CollPlant secures Korean patent for dermal filler technology
CollPlant launches BioFlex bioink kit for 3D bioprinting
Avaliação de ações da CollPlant rebaixada para Hold pela D. Boral Capital
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
CollPlant Biotechnologies marca reunião anual e extraordinária para 31 de dezembro
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Lucro da Collplant ADR veio abaixo das projeções por $0,41; receita menor do que estimativas
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
Ações da CollPlant caem após receita do 3º tri ficar abaixo das estimativas
CollPlant shares edge down as Q3 revenue falls short of estimates
CollPlant expande distribuição na América do Norte com novo centro logístico
CollPlant expands North American distribution with new logistics hub